EP2462246
Hröð byrjun og/eða endir á raunverulega stöðugri lyfjagjöf
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.9.2010EP published:
6.9.2017EP application number:
10819152.9
EP translation filed:
2.10.2017Grant published:
15.10.2017EPO information:
European Patent Register
Max expiry date:
20.9.2030Expiry date:
20.9.2024
Title:
RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY
Timeline
Today
21.9.2010EP application
6.9.2017EP Publication
2.10.2017Translation submitted
15.10.2017Registration published
20.9.2024Expires
Owner
Name:
i2O Therapeutics, Inc.Address:
700 Main Street, Cambridge, MA 02139, US
Inventor
Name:
ALESSI, Thomas, R.Address:
Hayward, CA, US
Name:
LUSKEY, Kenneth, L.Address:
Saratoga, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
358112 PDate:
24.6.2010Country:
US
Number:
277724 PDate:
28.9.2009Country:
US
Classification
Categories:
A61K 9/10, A61K 38/26, A61M 5/142
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 24.1.2018
Expires: 20.9.2018
Payer: Árnason Faktor
Number: 9
Paid: 31.8.2018
Expires: 20.9.2019
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 1.9.2019
Expires: 20.9.2020
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 1.9.2020
Expires: 20.9.2021
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 31.8.2021
Expires: 20.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 31.8.2022
Expires: 20.9.2023
Payer: Patice ehf.
Number: 14
Paid: 19.9.2023
Expires: 20.9.2024
Payer: Árnason Faktor ehf.